Proteomic analysis of lung cancer cells with natural resistance to gefitinib (IRESSA)

被引：0
|
作者：
Okano, Tetsuya [1 ]
Seike, Masahiro [1 ]
Gemma, Akihiko [1 ]
Kokubo, Yutaka [1 ]
Kataoka, Kiyoko [1 ]
Kudoh, Shoji [1 ]
Kondo, Tadashi [1 ]
Hirohashi, Setsuo [1 ]
机构：
[1] Nippon Med Sch, Tokyo, Japan
来源：
CANCER RESEARCH | 2006年 / 66卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3777
引用
收藏
页数：2
相关论文
共 50 条
  • [11] Gefitinib ('Iressa'): a new therapy for advanced non-small-cell lung cancer
    Reck, M
    Gatzemeier, U
    RESPIRATORY MEDICINE, 2005, 99 (03) : 298 - 307
  • [12] Systemic tumor embolism mimicking gefitinib ('IRESSA')-induced interstitial lung disease in a patient with lung cancer
    Umemura, S
    Kishino, D
    Tabata, M
    Kiura, K
    Hotta, K
    Nishii, K
    Tanimoto, Y
    Kanehiro, A
    Notohara, K
    Ueoka, H
    Tanimoto, M
    INTERNAL MEDICINE, 2005, 44 (09) : 979 - 982
  • [13] Cancer exosomal microRNAs from gefitinib-resistant lung cancer cells cause therapeutic resistance in gefitinib-sensitive cells
    Yoko Azuma
    Takehiko Yokobori
    Akira Mogi
    Toshiki Yajima
    Takayuki Kosaka
    Misaki Iijima
    Kimihiro Shimizu
    Ken Shirabe
    Hiroyuki Kuwano
    Surgery Today, 2020, 50 : 1099 - 1106
  • [14] Cancer exosomal microRNAs from gefitinib-resistant lung cancer cells cause therapeutic resistance in gefitinib-sensitive cells
    Azuma, Yoko
    Yokobori, Takehiko
    Mogi, Akira
    Yajima, Toshiki
    Kosaka, Takayuki
    Iijima, Misaki
    Shimizu, Kimihiro
    Shirabe, Ken
    Kuwano, Hiroyuki
    SURGERY TODAY, 2020, 50 (09) : 1099 - 1106
  • [15] Leptomycin B reduces primary and acquired resistance of gefitinib in lung cancer cells
    Liu, Zhongwei
    Gao, Weimin
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2017, 335 : 16 - 27
  • [16] The current situation:: Erlotinib (Tarceva®) and gefitinib (Iressa®) in non-small cell lung cancer
    Comis, RL
    ONCOLOGIST, 2005, 10 (07): : 467 - 470
  • [17] Gefitinib(Iressa) as first-line therapy in advanced non-small lung cancer
    Zimmermann, M
    Luthi, F
    Zouhair, A
    Bauer, J
    Leyvraz, S
    Stupp, R
    LUNG CANCER, 2005, 49 : S276 - S276
  • [18] Gefitinib ('Iressa', ZD1839) as treatment for non-small-cell lung cancer
    Razis, E
    Papadopoulos, S
    Skarlos, D
    Exarchakos, M
    Christodoulou, C
    Karina, M
    Xylouri, M
    Labropoulos, S
    BRITISH JOURNAL OF CANCER, 2003, 89 : S32 - S32
  • [19] Gefitinib ('Iressa', ZD1839) in relapsed non-small-cell lung cancer
    Reck, M
    Gatzemeier, U
    BRITISH JOURNAL OF CANCER, 2003, 89 : S32 - S33
  • [20] Proteomic analysis of the resistance to Aplidin in human cancer cells
    Gonzalez-Santiago, Laura
    Alfonso, Patricia
    Suarez, Yajaira
    Nunez, Antonio
    Garcia-Fernandez, Luis F.
    Alvarez, Enrique
    Munoz, Alberto
    Casal, J. Ignacio
    JOURNAL OF PROTEOME RESEARCH, 2007, 6 (04) : 1286 - 1294
12345